Endocrinology Noticias Destacadas Dec. 06, 2025 Study identifies patients who would benefit from redifferentiation therapy for thyroid cancer A study published in the January 2024 issue of Thyroid provides insights into which patients benefit most from radioactive redifferentiation therapy and raises questions about long-term efficacy and safety. Dec. 06, 2025 Surgery options for patients with severe obesity When comparing the two duodenal switch procedures for patients with severe obesity or diabetes, single-anastomosis duodeno-ileal bypass with sleeve gastrectomy is increasingly viewed as a balanced option. Aug. 21, 2025 GLP-1RA and thyroid cancer: New study suggests detection bias, not causation A Mayo Clinic study finds no overall increase in thyroid cancer risk with GLP-1RA therapy, suggesting early diagnoses likely reflect detection bias, not causation. Aug. 21, 2025 Ethanol ablation, an effective treatment option for insulinoma Mayo Clinic endocrinologists say ethanol ablation offers a safe, effective alternative to surgery for insulinoma, especially in patients with complex tumor positioning or surgical risk factors. Publicaciones EDICIÓN IMPRESA Ver la última edición y las versiones anteriores EDICIÓN DEL BOLETÍN ELECTRÓNICO Ver la última edición y las versiones anteriores 1 Parathyroid imaging helps more patients undergo curative parathyroidectomy 2 Machine learning predicts treatment options for pituitary tumors 3 Harnessing the hidden power of EHRs to transform thyroid cancer care 4 Unilateral adrenalectomy shows promising outcomes for selected patients with bilateral aldosterone excess 5 Clinical trial using subcutaneous pasireotide in patients with postbariatric surgery hypoglycemia Profesionales médicos Endocrinology